Scrip Asks…What Does 2023 Hold For Biopharma? Part 3: Global Headwinds
Tough Times Call For Resilience, Flexibility And Collaboration
Headwinds of political instability, violent conflict, inflation and recession accompany us into 2023. Scrip surveyed industry leaders on the impacts for biopharma.
